MSF responde à licença da Pfizer e do Medicines Patent Pool para o novo tratamento da Covid-19 – “O acordo, porém, cobre somente 53% da população mundial e exclui pessoas em diversos países de média renda, deixando esse medicamento promissor fora do alcance de milhões de pessoas.”

MSF responds to Pfizer and Medicines Patent Pool license for new Covid-19 treatment – Médecins Sans Frontières

Comentário no Twitter

Pfizer's deal w/ the Medicines Patent Pool for its COVID-19 treatment doesn't allow enough generic production & leaves this medicine out of reach for millions.

This is yet another restrictive voluntary license as cases continue to rise in many countries. https://t.co/WbVmUt9nrH

— Doctors w/o Borders (@MSF_USA) November 16, 2021